Gut health study for babies with heart disease
Part of Digestive system, Genetic & congenital, Heart & circulation clinical trials.
This study looks at a protein in the gut called calprotectin to better understand gut health in babies with heart disease. Your baby's participation could help doctors learn how to protect the gut during heart treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is 3 months old or younger.
- Your baby has a major heart condition and is being treated at a specialist heart centre.
- Your baby is expected to need heart surgery or a catheter-based procedure soon.
- Your baby does not have any known gut abnormality.
- Your baby does not have neutropenia (low white blood cell count).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to improve care for babies with serious heart defects, both before and after birth. It brings together pregnancy and newborn care to help identify and treat these heart problems as early as possible.
This study follows children with severe heart problems born recently to see how their brain development progresses. It helps doctors understand what support these children might need as they grow.
This trial studies a nutrition plan given around the time of heart surgery for babies with congenital heart disease. It may help improve how babies grow and recover by supporting feeding before and after the operation.
This study looks at the genetic material in the fluid around the baby (amniotic fluid) and in the placenta to better understand complex heart defects in unborn babies. The goal is to find new clues that could help doctors care for these babies before and after birth.
This study looks at babies under 2 who have cholestasis, a liver condition, to check for heart problems that are present at birth and to see how they are developing. The goal is to better understand these issues and help families.
This study looks at gut health in pregnant women with and without inflammatory bowel disease (IBD). It tracks a protein called calprotectin in stool samples, along with diet and baby health, to learn how IBD affects pregnancy and infant development.
Hear when a new Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.